First Analysis is a leading private growth equity investor. We have one of the longest records (29 years) in private capital investing, having invested more than $700 million across multiple highly diversified funds.
First Analysis invests mainly in the United States with a focus on our sectors of expertise: health care, technology/software, services, and clean-tech/chemicals. We help established companies become profitable leaders in large markets, funding growth plans and working closely with management in areas including strategy, recruitment, sales and marketing, and corporate development. Our flexible approach targets investing $3-10 million as lead investor or as a syndicate partner who brings valuable perspective to the table.
We build and maintain broad, deep, long-term domain expertise through a research and investment focus that encompasses both the private and public companies in our sectors of expertise. Relative to traditional approaches, this approach enables First Analysis to add distinctive value as an investor through:
- Keen understanding of our industries, for assistance with strategic planning
- Expansive networks of industry contacts, for assistance with recruitment, marketing, and selling
- Strong relationships with the institutional investor community, for subsequent financings
- A long-term perspective on company development—well beyond an IPO